Be Sweet to Babies During Nasolaryngoscopy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-12
SponsorThe Hospital for Sick Children

About this trial

The investigators want to know if sugar water containing 24% sucrose is helpful in reducing pain in babies during scopes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient <12 months of age;

Scheduled for an appointment with Dr. Nikolaus Wolter or Dr. Jennifer Siu, who are Staff Pediatric Otolaryngologists at the Hospital for Sick Children, or Meghan Tepsich, a complex airway Nurse Practitioner at SickKids;

Requiring flexible nasolaryngoscopy for diagnostic purposes;

Accompanied by caregivers who provided consent.

Disqualifiers

Patient >12 months of age

Infants <37 weeks corrected gestational age

Infants with decreased level of consciousness or delayed neuromuscular development with limited pain response

Infants who have received acute/urgent /emergent airway assessment such as respiratory distress or a foreign body, etc.

Trial design

Design model

Parallel

Treatments tested in this trial

  • 24% Sucrose

    Other intervention

    Participants will be given either sugar water (24% sucrose) randomly

  • Sterile water

    Other intervention

    Participants will be given sterile water randomly

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Sterile waterPlacebo comparator 1 intervention
Group B: Sucrose solutionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pain Scores

Clinical pain scores change after flexible nasolaryngoscopy (FNL) in 60 infants under 12 months of age following the use of sucrose solutions. The EVENDOL scale is a validated 15-point scale (range of 0-15) developed for children with presenting, prolonged, or procedural pain. Infant pain observations are ranked from 0-3 based on 5 different observations: (1) vocal or verbal expression, (2) facial expression, (3) movements, (4) postures, and (5) interactions with the environment. Higher scores mean a worse outcome (more pain).

Time frame
up to 7 months

Secondary outcomes

1

Crying time

Crying time (second - s) after FNL in 60 infants under 12 months of age following the use of oral sucrose solutions.

Time frame
up to 7 months
2

Maximum Heart rate

Maximum heart rate (beats per minute - bpm) as measured by a pulse oximeter during FNL in 60 infants under 12 months of age following the use of oral sucrose solutions.

Time frame
up to 7 months
3

Time to baseline

The time taken for heart rate to return to baseline (second - s) as measured by a pulse oximeter during FNL in 60 infants under 12 months of age following the use of oral sucrose solutions.

Time frame
up to 7 months
4

Plantar skin conductance

Plantar skin conductance (μS) during FNL in 60 infants under 12 months of age as measured by maximum peaks per second, following the use of oral sucrose solutions.

Time frame
up to 7 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.